Halma Matthew T J, Plothe Christof, Marik Paul, Lawrie Theresa A
EbMCsquared CIC, 11 Laura Place, Bath BA2 4BL, UK.
Center for Biophysical Osteopathy, Am Wegweiser 27, 55232 Alzey, Germany.
Microorganisms. 2023 May 17;11(5):1308. doi: 10.3390/microorganisms11051308.
In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm through several mechanisms. One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury. This review summarizes the known treatment options for long COVID-19 and vaccine injury, their mechanisms, and their evidentiary basis.
在新冠疫情危机之后，出现了预防和治疗两种相关病症的需求，即新冠疫苗损伤和新冠长期症状，这两种病症的病因至少部分可追溯到刺突蛋白，刺突蛋白可通过多种机制造成损害。一种重要的损害机制是血管性的，它由刺突蛋白介导，刺突蛋白是新冠疾病的一个共同要素，并且与接种新冠疫苗有关。鉴于有大量人群患有这两种相关病症，制定治疗方案以及考虑新冠长期症状和疫苗损伤患者的多样性势在必行。本综述总结了已知的新冠长期症状和疫苗损伤的治疗选择、其作用机制及其证据基础。
